These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 12538665)

  • 1. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
    Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
    J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
    Janssens S; Burns K; Tschopp J; Beyaert R
    Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
    Rao N; Nguyen S; Ngo K; Fung-Leung WP
    Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.
    Loiarro M; Sette C; Gallo G; Ciacci A; Fantò N; Mastroianni D; Carminati P; Ruggiero V
    J Biol Chem; 2005 Apr; 280(16):15809-14. PubMed ID: 15755740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
    Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
    J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
    Qin J; Qian Y; Yao J; Grace C; Li X
    J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
    Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN
    J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression.
    Janssens S; Burns K; Vercammen E; Tschopp J; Beyaert R
    FEBS Lett; 2003 Jul; 548(1-3):103-7. PubMed ID: 12885415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.
    Medzhitov R; Preston-Hurlburt P; Kopp E; Stadlen A; Chen C; Ghosh S; Janeway CA
    Mol Cell; 1998 Aug; 2(2):253-8. PubMed ID: 9734363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta.
    Eto A; Muta T; Yamazaki S; Takeshige K
    Biochem Biophys Res Commun; 2003 Feb; 301(2):495-501. PubMed ID: 12565889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
    Akira S; Hoshino K
    J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.